These studies were
done in Gwen V. Childs, Ph.D's lab, The University of Texas Medical Branch, Galveston, TX. Growth
hormone cells are one of the six hormone-bearing cell types in the anterior pituitary.
They are the most abundant cell type and secrete growth hormone to increase growth in
length of long bones. Other developmental roles have been postulated for growth hormone,
however. Our research project is related to one of these. It is linked to infertility
studies that show that the addition of growth hormone may be effective in promoting
pregnancy in some clinical cases that do not respond to more classical treatment.
Physician scientists have suggested that growth hormone may play a permissive role in
facilitating ovulation and other events leading up to implantation and successful
pregnancy. We are interested in its potential interactions in the pituitary itself. The
following menu catalogs the evidence we have thus far for a role for GH at the pituitary
level.
GH cells express gonadotropin beta subunit mRNA
during diestrus and proestrus (just before the preovulatory surge)
We began this work after we discovered that a subpopulation of GH
cells expressed messenger ribonucleic acid (mRNA) for the beta subunits of gonadotropins
just before ovulation. We used dual-labeling that detected mRNA for gonadotropins by in situ hybridization and growth
hormone antigens by immunolabeling.
A photograph of a dual-labeled growth hormone cell is
shown in this figure. The growth hormone cell (G) is labeled dark orange for growth
hormone antigens. The cell also contains messenger RNA for one of the gonadotropins,
follicle stimulating hormone. This is labeled dense gray-black (F) U=unlabeled cell. We
suggest that it has become a transitional gonadotrope to augment the ovulatory surge of
gonadotropins.

Counts of cells bearing GH antigens and gonadotropin
mRNAs are shown in this graph. These data illustrate that significant percentages of GH
cells express LH or FSH mRNA on the day of ovulation. After ovulation, these percentages
drop to minimal levels.
For more information, see:
Childs, G.V. , Unabia G., Rougeau D. Cells that
Express Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH) Beta ( ) Subunit
mRNAs during the Estrous Cycle: The major contributors contain LH , FSH and/or Growth
Hormone, Endocrinology, 134: 990-997 1994.

Hypotheses
to test:
There are two working hypotheses to explain this labeling
pattern. The first states that subsets of GH cells may become transitional gonadotropes to
support the LH surge. They may be the medium-sized subset that appears before ovulation
and secretes better than the largest gonadotropes.
The second hypothesis states that GH antigens are binding
to GH receptors in gonadotropes. This would point to GH as a regulatory molecule for the
gonadotropes themselves. The fact that gonadotropes have GH receptors suggests that they
may be able to receive such regulation. However, electron microscopic data shown below indicates that the gonadotropin molecules are
being translated by somatotropes which supports the first hypothesis.
These hypotheses are being tested in an NIH grant:
R01 HD 33915 "Novel Somatotrope functions during ovulation" 1996-2000

Questions that address Hypothesis 1:
Test
for GnRH binding: Do GH cells bind the neuropeptide releasing hormone
that binds gonadotropes? (Gonadotropin Releasing hormone)
One way to test the first hypothesis would be to determine if the transitional
"somatogonadotrope" binds the neuropeptide Gonadotropin releasing hormone
(GnRH). We used dual affinity cytochemistry labeling protocols
to detect GnRH on subsets of pituitary cells and found that cells with GH antigens did
increase binding (to about 40% of GH cells) just before ovulation. At the same time, there
was an increase in the percentages of gonadotropes that bound GnRH to 90% of gonadotropes.
This supports the hypothesis that these GH cells may be transitional gonadotropes. The
figure to the left illustrates the dual-labeling data. The figure was reproduced as a
negative image to show the labeling better. Growth hormone cells (G) are immunolabeled
blue for growth hormone antigens. The white label (arrows) shows that this cell also binds
the neuropeptide, gonadotropin releasing hormone (GnRH). The labeling is mostly on the
cell periphery. This releasing hormone may help convert these cells to transitional
gonadotropes just before ovulation.
For more information, please see:
Childs, G.V., Unabia, G and Miller, BT Cytochemical
detection of GnRH binding sites on rat pituitary cells with LH, FSH and GH antigens during
diestrous upregulation. Endocrinology 134: 1943-1951 1994.
Can expression of GnRH receptors by GH cells be regulated by inhibin or
activin?
It is well known, from our earlier studies, that
percentages of GnRH receptive cells increase 4-fold during diestrus to reach a peak in
early proestrus, on the morning before ovulation. Expression of GnRH receptors is
seen in over 90% of LH or 88% of FSH cells during this peak. In addition, as shown
above, GH cells express GnRH receptors (over 38% of the cells) only during this peak
period.
Can this expression be regulated by factors known to
stimulate (activin) or inhibit (inhibin) GnRH receptors? Studies recently completed
and published show that GnRH receptive cells can be increased in diestrous rat pituitary
cells by overnight incubation in 60 ng/ml activin. When the cell types were identified by
dual labeling affinity
cytochemistry, both LH and FSH gonadotropes were affected. In addition, activin
increased GnRH receptor expression by GH cells from either diestrous or proestrous rats.
The increase was from 38-60% of GH cells, which is a higher expression than
normally seen in proestrus. At the same time, inhibin causes a decrease in
expression of GnRH receptors by LH or FSH cells and also GH cells from populations taken
from proestrous rats. These data suggest that expression of GnRH receptors by GH
cells can be regulated by the reproductive hormones that normally regulate them in
gonadotropes.
This photo shows GH cells bound to
Biotinylated GnRH. They were taken from Proestrous rats. As in the above photo, the
binding is in dense gray or lavendar-black patches on the cells (noted by arrows).
The immunolabel for GH is orange-amber.
The following photograph shows the results of treatment
with activin for 15 hours. The cells were taken from diestrus rats and treated with
60 ng/ml activin during the culture period. The labeling for Biotinylated GnRH has
expanded on the GH cells and is seen to cover a larger part of the surface area (arrows).
The GH cells are often in clusters which may suggest that activin has stimulated mitosis.
GH is detected by the orange-amber label. This can be measured by image
analysis and the increase in the average area of label/cell was statistically significant.
The references below point to papers that show these data.

For more information, please see:
Childs GV, Miller, B, and Miller W. 1997 Differential
effects of inhibin on gonadotropin stores and gonadotropin releasing hormone binding to
pituitary cells from cycling female rats. Endocrinology 138: 1577-1584.
Childs GV and Unabia G 1997 Cytochemical studies of
the effects of activin on gonadotropin releasing hormone (GnRH) binding by pituitary
gonadotropes and growth hormone cells. J Histochem Cytochem 45:
1603-1610.

Childs, G.V. , Unabia G., Rougeau D. Cells that Express
Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH) Beta ( ) Subunit mRNAs
during the Estrous Cycle: The major contributors contain LH , FSH and/or Growth Hormone,
Endocrinology, 134: 990-997 1994.
Childs, G.V.,
Unabia, G and Miller, BT Cytochemical detection of GnRH binding sites on rat pituitary
cells with LH, FSH and GH antigens during diestrous upregulation. Endocrinology 134:
1943-1951 1994.
Childs, G.V. Division of Labor among Gonadotropes, Vitamins and
Hormones, 50: 217- 283 1995
Childs, GV, Cytochemical studies of multifunctional gonadotropes.
Microscopy Research and Techniques. 39: 114-130, 1997
Childs GV, Miller, B, and Miller W. 1997 Differential effects of inhibin
on gonadotropin stores and gonadotropin releasing hormone binding to pituitary cells from
cycling female rats. Endocrinology 138: 1577-1584.
Childs GV and Unabia G 1997 Cytochemical studies of the effects of
activin on gonadotropin releasing hormone (GnRH) binding by pituitary gonadotropes and
growth hormone cells. J Histochem Cytochem 45: 1603-1610.

Other pages:
Protocols and related web pages
covering gonadotropes:
| Affinity
Cytochemistry | In situ hybridization histochemistry | Go to Childs Home Page |
Last updated: 09/03/01
URL Address: cellbio.utmb.edu/childs/GH1.htm
Program Director and WebMistress: Gwen V. Childs, Ph.D.,
Email: gvchilds@utmb.edu
© copyright 1995 Gwen V. Childs, Ph.D.
|